Your English writing platform
Discover LudwigExact(1)
After an inclusion period of more than 10 years they reported a 5-year relapse free survival of 33% and an overall survival of 44% for a non-randomized trial with 214 enrolled stage III melanoma patients.
Similar(59)
We enroll stage IV (or stage III lung or pancreatic) patients with the goal of establishing a supportive relationship and providing ongoing coping and communication support from the early treatment phase for late-stage cancer through end of life.
Twenty-five patients were enrolled in stage I of this phase I study.
Patients in the overall AVAiL population generally had slightly more favourable prognostic features when compared with those in the E4599 trial [ 9]: they were younger (median age 57 59 versus 63 years), 8% had dry stage IIIb (0% in E4599, which only enrolled wet stage IIIb) and a high proportion had adenocarcinoma histology (82%–85%) and were never smokers (22%26%%) [ 10, 11].
If <2/20 patients achieved a response (PR or CR per RECIST 1.1) using a central independent radiology review in Stage 1, then the treatment would be deemed futile and no additional patients would be enrolled into Stage 2 for that treatment schedule.
One patient was erroneously enrolled with stage II disease.
Two patients were analyzed for gene mutations but omitted from statistical analysis as protocol violators; histopathological examination revealed one patient (Epi089) to harbor a sarcomatoid tumor, while one patient Epi232 was erroneously enrolled with stage II disease.
A total of 21 patients were enrolled in stage II of the study.
Twenty-five patients were enrolled in stage I of the study to determine the recommended dose of BNP7787.
This was a Phase II open-label, single-arm, multicenter study designed to enroll up to 54 evaluable patients, with 19 evaluable patients to be enrolled into Stage 1 (safety assessment) of the study.
Zaanan et al (2011) enrolled 303 stage III colon cancer patients received FOLFOX chemotherapy, 34 cases with dMMR tumour (11.2%), compared with 269 cases with pMMR tumour (73.8%), 3-year DFS of dMMR showed great benefit (90.5% vs 73.8%, P=0.027).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com